Publications by authors named "Ryan Massa"

Claim this Profile
L
Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanoma.
Lilit Karapetyan, Anthony R Cillo, Shuaichao Wang, Arivarasan Karunamurthy, Ryan C Massa

medRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of and Testing in Patients With GI Cancer: A Prospective, Nonrandomized Clinical Trial.
Sony Tuteja, Mari Angelica S Cayabyab, Glenda Hoffecker, Lisa A Varughese, Jean de Dieu Ndayishimiye, Ryan Massa

JCO Precis Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8 T cells to promote antitumor immunity.
Anthony R Cillo, Carly Cardello, Feng Shan, Lilit Karapetyan, Sheryl Kunning, Ryan C Massa

Cell· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer.
Thomas B Karasic, Timothy J Brown, Charles Schneider, Ursina R Teitelbaum, Kim A Reiss, Ryan C Massa

Oncologist· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in the Management of Patients With HER2-Amplified Colorectal Cancer.
Timothy J Brown, Ryan C Massa

JCO Oncol Pract· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial.
Kim A Reiss, Rosemarie Mick, Ursina Teitelbaum, Mark O'Hara, Charles Schneider, Ryan Massa

Lancet Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing and Screening to Guide Chemotherapy Dosing.
Lisa A Varughese, Madhuri Bhupathiraju, Glenda Hoffecker, Shannon Terek, Margaret Harr, Ryan C Massa

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving standards of care for neoadjuvant and adjuvant therapy in esophageal, gastroesophageal junction, and gastric cncer.
William J Chapin, Ryan C Massa, Jennifer R Eads

Clin Adv Hematol Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anemia in a young Guinean male.
Nicholas S Wilcox, Chantal Tapé, Anthony J Cordisco, Minh T Than, Leah Zuroff, Ryan C Massa

Clin Case Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8 T cells contribute to survival in patients with COVID-19 and hematologic cancer.
Erin M Bange, Nicholas A Han, Paul Wileyto, Justin Y Kim, Sigrid Gouma, Ryan Massa

Nat Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer.
Erin M Bange, Nicholas A Han, Paul Wileyto, Justin Y Kim, Sigrid Gouma, Ryan Massa

Res Sq· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation.
Lisa A Varughese, Kelsey S Lau-Min, Christine Cambareri, Nevena Damjanov, Ryan Massa

Pharmacotherapy· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis